Presence of opiate alkaloid-selective μ3 receptors in cultured astrocytes and in brain and retina

M. H. Makman, Kostantin Dobrenis, Sherry A. Downie, W. D. Lyman, B. Dvorkin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Opiate alkaloid-selective receptors, insensitive to opioid peptides and differing from classical opioid receptors in other respects, mediate inhibition by morphine of activation of human peripheral blood monocytes and are present on other macrophage cell types as well, including microglia. This receptor has been tentatively designated as a μ3 subtype. The present studies provide evidence for the presence of this receptor in cultures of astrocytes derived from human fetal brain, in cultures of feline astrocytes and in an immortalized feline astrocyte cell line. Also, neonatal and adult rat striatum and other brain regions, assayed in the presence of agents that blocked classical μ, δ and κ binding sites, were found to contain additional saturable 3H-morphine binding sites that exhibited the pharmacology of μ3 receptors. Additionally, μ3 receptor sites were present in rat retina and in the avascular guinea pig retina, retinas that lack endogenous opioid peptides and that do not contain classical opioid peptide-sensitive μ, δ or κ binding sites. For each of these preparations, with 3H-morphine as ligand, binding sites were saturable and displaced by morphine, etorphine, naloxone, diprenorphine and morphine 6-glucuronide, but not by morphine 3-glucuronide, fentanyl, benzomorphans, or by enkephalins, dynorphin, β-endorphin or other opioid peptides. These sites also could be distinguished from other (μ, δ and κ) sites on the basis of sensitivity to sulfhydryl compounds. It is proposed that μ3 receptors occur on astrocytes as well as on microglia in brain and retina, where they function to modulate responses to injury and infection, as has been proposed previously for these receptors in the immune system.

Original languageEnglish (US)
Pages (from-to)23-27
Number of pages5
JournalAdvances in Experimental Medicine and Biology
Volume402
StatePublished - 1996

Fingerprint

Opiate Alkaloids
Opioid Peptides
Astrocytes
Morphine
Retina
Brain
Binding Sites
Felidae
Microglia
Rats
Benzomorphans
Diprenorphine
Etorphine
Endorphins
Dynorphins
Enkephalins
Macrophages
Immune system
Opioid Receptors
Fentanyl

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Presence of opiate alkaloid-selective μ3 receptors in cultured astrocytes and in brain and retina. / Makman, M. H.; Dobrenis, Kostantin; Downie, Sherry A.; Lyman, W. D.; Dvorkin, B.

In: Advances in Experimental Medicine and Biology, Vol. 402, 1996, p. 23-27.

Research output: Contribution to journalArticle

@article{073d5011fb5a4569a34a2c2ae81658d6,
title = "Presence of opiate alkaloid-selective μ3 receptors in cultured astrocytes and in brain and retina",
abstract = "Opiate alkaloid-selective receptors, insensitive to opioid peptides and differing from classical opioid receptors in other respects, mediate inhibition by morphine of activation of human peripheral blood monocytes and are present on other macrophage cell types as well, including microglia. This receptor has been tentatively designated as a μ3 subtype. The present studies provide evidence for the presence of this receptor in cultures of astrocytes derived from human fetal brain, in cultures of feline astrocytes and in an immortalized feline astrocyte cell line. Also, neonatal and adult rat striatum and other brain regions, assayed in the presence of agents that blocked classical μ, δ and κ binding sites, were found to contain additional saturable 3H-morphine binding sites that exhibited the pharmacology of μ3 receptors. Additionally, μ3 receptor sites were present in rat retina and in the avascular guinea pig retina, retinas that lack endogenous opioid peptides and that do not contain classical opioid peptide-sensitive μ, δ or κ binding sites. For each of these preparations, with 3H-morphine as ligand, binding sites were saturable and displaced by morphine, etorphine, naloxone, diprenorphine and morphine 6-glucuronide, but not by morphine 3-glucuronide, fentanyl, benzomorphans, or by enkephalins, dynorphin, β-endorphin or other opioid peptides. These sites also could be distinguished from other (μ, δ and κ) sites on the basis of sensitivity to sulfhydryl compounds. It is proposed that μ3 receptors occur on astrocytes as well as on microglia in brain and retina, where they function to modulate responses to injury and infection, as has been proposed previously for these receptors in the immune system.",
author = "Makman, {M. H.} and Kostantin Dobrenis and Downie, {Sherry A.} and Lyman, {W. D.} and B. Dvorkin",
year = "1996",
language = "English (US)",
volume = "402",
pages = "23--27",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Presence of opiate alkaloid-selective μ3 receptors in cultured astrocytes and in brain and retina

AU - Makman, M. H.

AU - Dobrenis, Kostantin

AU - Downie, Sherry A.

AU - Lyman, W. D.

AU - Dvorkin, B.

PY - 1996

Y1 - 1996

N2 - Opiate alkaloid-selective receptors, insensitive to opioid peptides and differing from classical opioid receptors in other respects, mediate inhibition by morphine of activation of human peripheral blood monocytes and are present on other macrophage cell types as well, including microglia. This receptor has been tentatively designated as a μ3 subtype. The present studies provide evidence for the presence of this receptor in cultures of astrocytes derived from human fetal brain, in cultures of feline astrocytes and in an immortalized feline astrocyte cell line. Also, neonatal and adult rat striatum and other brain regions, assayed in the presence of agents that blocked classical μ, δ and κ binding sites, were found to contain additional saturable 3H-morphine binding sites that exhibited the pharmacology of μ3 receptors. Additionally, μ3 receptor sites were present in rat retina and in the avascular guinea pig retina, retinas that lack endogenous opioid peptides and that do not contain classical opioid peptide-sensitive μ, δ or κ binding sites. For each of these preparations, with 3H-morphine as ligand, binding sites were saturable and displaced by morphine, etorphine, naloxone, diprenorphine and morphine 6-glucuronide, but not by morphine 3-glucuronide, fentanyl, benzomorphans, or by enkephalins, dynorphin, β-endorphin or other opioid peptides. These sites also could be distinguished from other (μ, δ and κ) sites on the basis of sensitivity to sulfhydryl compounds. It is proposed that μ3 receptors occur on astrocytes as well as on microglia in brain and retina, where they function to modulate responses to injury and infection, as has been proposed previously for these receptors in the immune system.

AB - Opiate alkaloid-selective receptors, insensitive to opioid peptides and differing from classical opioid receptors in other respects, mediate inhibition by morphine of activation of human peripheral blood monocytes and are present on other macrophage cell types as well, including microglia. This receptor has been tentatively designated as a μ3 subtype. The present studies provide evidence for the presence of this receptor in cultures of astrocytes derived from human fetal brain, in cultures of feline astrocytes and in an immortalized feline astrocyte cell line. Also, neonatal and adult rat striatum and other brain regions, assayed in the presence of agents that blocked classical μ, δ and κ binding sites, were found to contain additional saturable 3H-morphine binding sites that exhibited the pharmacology of μ3 receptors. Additionally, μ3 receptor sites were present in rat retina and in the avascular guinea pig retina, retinas that lack endogenous opioid peptides and that do not contain classical opioid peptide-sensitive μ, δ or κ binding sites. For each of these preparations, with 3H-morphine as ligand, binding sites were saturable and displaced by morphine, etorphine, naloxone, diprenorphine and morphine 6-glucuronide, but not by morphine 3-glucuronide, fentanyl, benzomorphans, or by enkephalins, dynorphin, β-endorphin or other opioid peptides. These sites also could be distinguished from other (μ, δ and κ) sites on the basis of sensitivity to sulfhydryl compounds. It is proposed that μ3 receptors occur on astrocytes as well as on microglia in brain and retina, where they function to modulate responses to injury and infection, as has been proposed previously for these receptors in the immune system.

UR - http://www.scopus.com/inward/record.url?scp=0029835802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029835802&partnerID=8YFLogxK

M3 - Article

C2 - 8787639

AN - SCOPUS:0029835802

VL - 402

SP - 23

EP - 27

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -